Alteration of cell cycle regulators correlates with survival in epithelial ovarian cancer patients1 1Authors Hashiguchi and Tsuda contributed equally to this article.
- 1 February 2004
- journal article
- Published by Elsevier in Human Pathology
- Vol. 35 (2), 165-175
- https://doi.org/10.1016/j.humpath.2003.07.018
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Regulation of the G2/M transition by p53Oncogene, 2001
- p53 mutation does not affect prognosis in ovarian epithelial malignanciesThe Journal of Pathology, 2001
- Absence of Germline CHK2 Mutations in Familial Gastric CancerJapanese Journal of Cancer Research, 2000
- Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathwayOncogene, 1999
- Overexpression of cyclin B1 in human colorectal cancersZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- rad -Dependent Response of the chk1 -Encoded Protein Kinase at the DNA Damage CheckpointScience, 1996
- Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosisNature Medicine, 1996
- p53 gene mutations and protein accumulation in human ovarian cancer.Proceedings of the National Academy of Sciences, 1993
- The cdc25 protein contains an intrinsic phosphatase activityCell, 1991
- Study of ovarian tumors treated at Nagoya University Hospital, 1965–1988Gynecologic Oncology, 1990